ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
The enzymes maker Novozymes has paid $90 million to buy the Irish probiotics company PrecisionBiotics, which has commercialized several products for human gut health. Novozymes says the global market for human probiotics is worth over $5.5 billion annually. Combining enzymes and probiotics that work synergistically is one area for new product development, says Novozymes CEO Ester Baiget.
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on X